Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy | Synapse
March 3, 2026
Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy
GO
Gabriela R. Oates
University of Alabama at Birmingham
RG
R. Geurs
University of Alabama at Birmingham
CM
Cathy Mims
Ver todo
Puntos clave
The clinical intervention shows promising acceptability among participants with cystic fibrosis, suggesting a positive response.
Preliminary efficacy results indicate improvements in measured biomarkers related to smoke exposure effects.
Feasibility assessed in a multi-site analysis under various conditions, focusing on practical implementation.
Indicates a need for larger trials to confirm the efficacy and long-term benefits of the intervention for cystic fibrosis.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Oates et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75d45c6e9836116a2703e
https://doi.org/https://doi.org/10.1016/j.jcf.2026.01.007